| ART | Antiretroviral therapy |
| BMI | Body mass index |
| CCR5 | C-C chemokine receptor type 5 |
| CRP | C-reactive protein |
| DNA | Deoxyribonucleic acid |
| GALT | Gut-associated lymphoid tissue |
| G-CSF | Granulocyte colony-stimulating factor |
| GlycA | Glycoprotein acetylation |
| GM-CSF | Granulocyte macrophage colony-stimulating factor |
| HIV | Human immunodeficiency virus |
| I-BABP | Ileal bile acid-binding protein |
| ICAM-1 | Intercellular adhesion molecule 1 |
| I-FABP | Intestinal fatty acid-binding protein |
| IL-6 | Iinterleukin-6 |
| INSTI | Integrase strand transfer inhibitor |
| LPS | Lipopolysaccharide |
| MeSH | Medical Subject Headings |
| NCD | Noncommunicable disease |
| NRTI | Nucleoside reverse transcriptase inhibitor |
| NNRTI | Non-nucleoside reverse transcriptase inhibitor |
| PDGF-BB | Platelet derived growth factor subunit B |
| PI | Protease inhibitor |
| PLWH | People living with HIV |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PRISMA-ScR | PRISMA for Scoping Reviews |
| RANTES | Regulated on activation, normal T-cell expressed and secreted |
| RNA | Ribonucleic acid |
| rRNA | Ribosomal ribonucleic acid |
| sCD14 | Soluble cluster of differentiation 14 |
| sCD40 | Soluble cluster of differentiation 40 |
| sCD163 | Soluble cluster of differentiation 163 |
| SCFA | Short-chain fatty acid |
| sIL-2r | Soluble interleukin-2 receptor |
| WHO | World Health Organization |